The increasing interest in effective weight management has spurred considerable investigation into groundbreaking treatments. Lately , Retatrutide, a dual -action hormone and glucagon-like peptide-1 (GLP-1) receptor stimulator, has exhibited promising results in medical trials, implying potential for significant weight reduction . As a result , num